Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • VRSK vs GSK✓SelectedUSD · GSKVRSK vs GSK performance historyLatest closeAs of+0.78%11/20
Stock and ETF performance explorer

VRSK vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-8.0%
GSK return
+6.1%
Excess return
-14.2%
Maximum drawdown
-30.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.8%-0.1%+0.9%+0.8%
7D-2.8%-5.3%+2.6%-2.6%
30D+5.1%-3.7%+8.7%+5.1%
3M+8.0%-7.3%+15.2%+7.3%
6M+19.1%-4.2%+23.3%+19.3%
YTD-8.9%+0.9%-9.8%-12.2%
1Y-8.0%+7.3%-15.3%-12.9%
All-8.0%+6.1%-14.2%-12.9%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling